Información del artículo
El Texto completo está disponible en PDF
References
[1.]
P. Bassas, R. Bartralot, V. García-Patos.
Anticoagulación y antiagregación en dermatología.
Actas Dermosifiliogr, 100 (2009), pp. 7-16
[2.]
M. Alan, H. Goldberg.
Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy.
Dermatol Surg, 28 (2002), pp. 992-998
[3.]
M.E. Bertrand.
When and how to discontinue antiplatelet therapy.
Eur Heart J Suppl, 10 (2008), pp. A35-A41
[4.]
A.Y. Kirkorian, B.L. Moore, J. Siskind, E.S. Marmur.
Perioperative management of anticoagulant therapy during cutaneous surgery: 2005 survey of Mohs surgeons.
Dermatol Surg, 33 (2007), pp. 1189-1197
[5.]
O. Kovich, C.C. Otley.
Perioperative management of anticoagulants and platelet inhibitors for cutaneous surgery: a survey of current practice.
Dermatol Surg, 28 (2002), pp. 513-517
[6.]
J. Thachil, A. Gatt, V. Martlew.
Management of surgical patients receiving anticoagulation and antiplatelet agents.
Br J Surg, 95 (2008), pp. 1437-1448
[7.]
C.L. Grines, R.O. Bonow, D.E. Casey, T.J. Gardner, P.B. Lockhart, D.J. Moliterno, et al.
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.
Circulation, 115 (2007), pp. 813-818
Copyright © 2010. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
